Eczema is not a bacterial disease. It’s a chronic inflammatory skin condition driven by a combination of genetic factors, immune system dysfunction, and environmental triggers. However, bacteria play a significant and often underappreciated role in making eczema worse. The relationship between eczema and bacteria is one of the most important things to understand about managing the condition, because bacterial overgrowth on eczema-prone skin can trigger flares, resist treatment, and sometimes cause dangerous infections.
What Actually Causes Eczema
The root cause of eczema (formally called atopic dermatitis) is a defective skin barrier combined with an overactive immune response. In healthy skin, a protein called filaggrin helps form a tight, waterproof outer layer that keeps moisture in and irritants out. Many people with eczema carry genetic mutations that reduce filaggrin production, leading to increased water loss through the skin, pH changes, and chronic dehydration of the outer skin layer.
This weakened barrier lets in environmental irritants like fragrances, harsh detergents, preservatives, and even airborne chemicals like formaldehyde. Once these penetrate the skin, the immune system overreacts. People with eczema tend to have an imbalance in their immune signaling that favors allergic-type inflammation, which creates the redness, swelling, and intense itch that define the condition. So eczema starts with your genes and your immune system, not with an infection.
Why Bacteria Thrive on Eczema Skin
Even though bacteria don’t cause eczema, they colonize eczema-prone skin at remarkably high rates. Staphylococcus aureus, a common bacterium found on about 10% of healthy people’s skin, can be cultured from affected skin in 93% of eczema patients and from their uninvolved, normal-looking skin in 70% of cases. That difference is staggering, and it’s not a coincidence.
Eczema skin essentially rolls out the welcome mat for staph bacteria in several ways. The reduced filaggrin levels change the skin’s pH, removing a natural defense that normally inhibits bacterial growth. The outer skin cells become misshapen, giving bacteria better surfaces to grip. The immune signaling molecules that dominate in eczema actively suppress the skin’s natural antibiotic compounds, called antimicrobial peptides, which would otherwise keep staph in check. On top of all this, the overall diversity of the skin’s bacterial community drops in eczema patients, meaning the helpful bacteria that would normally compete with staph for resources are diminished.
The Vicious Cycle of Bacteria and Flares
Once staph bacteria establish themselves on eczema skin, they don’t just sit there passively. They produce toxins called superantigens that activate large numbers of immune cells at once, amplifying inflammation far beyond what the original eczema trigger would cause on its own. This creates a self-reinforcing loop: the inflammation from eczema invites staph colonization, and the staph colonization worsens the inflammation, which further damages the skin barrier, which invites more bacteria.
The bacteria also trigger the skin to release a signaling molecule that produces intense itching. Scratching damages the skin further, opening new entry points for bacteria and deepening the cycle. Studies have found that higher levels of staph colonization correlate with higher levels of the antibodies associated with allergic reactions, suggesting that the bacterial burden directly influences how severe the disease becomes.
How Biofilms Make Eczema Harder to Treat
One of the more frustrating aspects of staph bacteria on eczema skin is their ability to form biofilms. These are structured communities of bacteria that encase themselves in a protective slime layer, attaching firmly to the skin surface. Among staph isolates taken from eczema patients, 85% were strong biofilm producers.
Biofilms are a serious problem for several reasons. They are highly resistant to both antibiotics and the body’s own immune defenses. Immune cells that would normally engulf and destroy bacteria cannot penetrate the biofilm structure effectively. These bacterial communities have been found colonizing sweat gland ducts adjacent to eczema lesions, giving them a protected niche that’s difficult to reach with topical treatments.
Lab studies show that skin cells exposed to staph biofilms begin dying within just three hours, while the same bacteria in their free-floating form cause no significant damage in that timeframe. The dying skin cells release signals that further amplify the allergic-type immune response and suppress the skin’s antimicrobial defenses, creating yet another feedback loop that favors bacterial persistence.
Bleach Baths: Not What You Might Think
Dilute bleach baths have been widely recommended as a way to reduce bacterial load on eczema skin. The standard advice involves adding a small amount of household bleach to a full bathtub, creating a roughly 0.005% sodium hypochlorite solution. Research has shown, however, that this concentration has no direct antibacterial effect against staph bacteria. In controlled experiments, there was no significant difference in bacterial survival between the bleach bath concentration and plain water.
To actually kill staph, bleach concentrations would need to reach at least 0.03%, which is six times the recommended bath concentration and toxic to human skin cells. Some patients do report improvement with bleach baths, but any benefit likely comes from mechanisms other than bacterial killing, possibly anti-inflammatory effects on the skin itself. This finding underscores how difficult it is to address the bacterial component of eczema through simple antimicrobial strategies.
Bacterial Transplants as Treatment
A more promising approach involves replacing harmful bacteria with beneficial ones. In an early clinical trial conducted by researchers at the National Institutes of Health, a healthy skin bacterium called Roseomonas mucosa was applied topically to 10 adults and 5 children with eczema twice weekly for six weeks. Interestingly, strains of this bacterium collected from healthy volunteers improved eczema outcomes, while strains collected from eczema patients actually worsened them.
Participants who received the healthy bacterial transplants experienced significant decreases in disease severity, reduced need for topical steroids, and lower staph burden on their skin. Even after a four-week period without treatment, the steroid-sparing effects persisted. These results are preliminary, but they highlight how much the bacterial ecosystem on the skin matters for eczema management.
Signs Your Eczema Has Become Infected
Because staph bacteria are already present on most eczema skin, there’s a meaningful distinction between colonization (bacteria living on the surface) and active infection (bacteria invading the tissue and causing harm). Recognizing when eczema has crossed that line is important.
Early signs of a secondary bacterial infection include skin that looks more red or darker than your usual flare, with a subtle glistening or shimmering quality that’s sometimes compared to orange body shimmer, best seen in natural light. As infection progresses, you’ll notice weeping fluid and crusting with a yellow or golden tinge. The eczema may stop responding to your usual treatments, spread more rapidly, or feel warmer than typical flares.
Untreated bacterial infections on eczema skin can progress to impetigo, cellulitis, or skin abscesses. In more serious cases, the infection can become systemic, potentially causing bacteremia (bacteria in the bloodstream), bone infections, joint infections, or in rare cases, heart valve infections. Warning signs of systemic spread include persistent fever, lethargy, bone tenderness, joint swelling, or a generally ill appearance. These complications are uncommon but represent real risks, particularly in children and people with widespread eczema.
What This Means for Managing Eczema
Understanding the bacterial dimension of eczema changes how you think about managing it. The primary goal remains repairing and protecting the skin barrier through consistent moisturizing and avoiding known triggers. But paying attention to signs of bacterial overgrowth, keeping skin clean without stripping it of helpful microbes, and acting quickly when infection signs appear are all part of effective long-term management.
The fact that eczema skin has reduced microbial diversity also suggests that overly aggressive antimicrobial approaches, like frequent antibiotic use, could backfire by further depleting the beneficial bacteria that help keep staph in check. The emerging picture is one where the goal isn’t to sterilize the skin but to restore a healthy bacterial balance that supports the skin barrier rather than undermining it.